AKT Health – Frequently Asked Questions (FAQ)

This FAQ provides clear answers about AKT Health’s services, products, AI capabilities, and partnerships across the life sciences ecosystem.

What are AKT Health's four service areas?

AKT Health operates across four core service areas: Clinical (clinical trials, pharmacovigilance, regulatory affairs, RWE, medical writing, decentralised trials), Medical (medical affairs analytics, KOL management, communications, HCP engagement), Commercial (market access, launch strategy, analytics, omnichannel engagement), and Outcome (real-world evidence, patient outcome analytics, HEOR, value demonstration).

What does AKT stand for?

AKT stands for Applied Knowledge & Technology in Healthcare, reflecting the integration of domain expertise with advanced technology.

What products does AKT Health offer?

AKT Health offers: Impakt Health, Impakt Life, Impakt eClinical-DCT, and the Certara Software Suite distributed across Asia.

What is Impakt Health?

Impakt Health is a Remote Patient Monitoring platform and certified Software as a Medical Device (SaMD) in Japan (PMDA, August 2025). It connects wearables, IoT sensors, and patient-reported outcomes into clinical workflows.

Does AKT Health use AI, IoT, and blockchain?

Yes. AI powers IoT powers Impakt Health and Impakt Life, and blockchain ensures secure, tamper-evident healthcare data systems.

What is AKT Health's relationship with Certara?

AKT Health is the distributor and promoter of Certara’s biosimulation and regulatory software across Japan, India, Sri Lanka, Bangladesh, and Pakistan.